The global oncology blood testing market is on the brink of a major transformation, with projections indicating a significant rise from USD 3,851.7 million in 2022 to USD 18,278.2 million by 2032.

If conducted every year or every other year, the multi-cancer early detection (MCED) blood test could help more people survive cancer, researchers reported May 8 in BMJ Open. “Both annual and ...

The test involves providing a small poo sample to be checked for tiny amounts of blood, which could be caused by cancer. If you're 75 or over, you can ask for a kit every two years by phoning the ...